John Clayton Taylor is CHIEF EXECUTIVE OFFICER of IDERA PHARMACEUTICALS, INC.. Currently has a direct ownership of 1.47 Million shares of IDRA, which is worth approximately $4.42 Million. The most recent transaction as insider was on Jan 17, 2023, when has been sold 1,341,764 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.47M
0% 3M change
0% 12M change
Total Value Held $4.42 Million

John Clayton Taylor Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 17 2023
BUY
Exercise of conversion of derivative security
-
1,341,764 Added 47.73%
1,469,482 Common Stock
Sep 28 2022
BUY
Grant, award, or other acquisition
-
2,171,214 Added 50.0%
2,171,214 Common Stock, par valu...
JCT

John Clayton Taylor

CHIEF EXECUTIVE OFFICER
Exton, PA

Track Institutional and Insider Activities on IDRA

Follow IDERA PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IDRA shares.

Notify only if

Insider Trading

Get notified when an Idera Pharmaceuticals, Inc. insider buys or sells IDRA shares.

Notify only if

News

Receive news related to IDERA PHARMACEUTICALS, INC.

Track Activities on IDRA